Anuh Pharma Complete Financial Statements

In FYNone, Anuh Pharma (ANUHPHR) reported revenue ₹778 Cr, net profit ₹42 Cr and EPS ₹6.20, with a net profit margin of 7.0% and ROE of 14.4%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see ANUHPHR stock price BSE.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.00% 2025 data
EBITDA Margin 10.43% 2025 data
Operating Margin 9.00% 2025 data
Return on Assets 9.27% 2025 data
Return on Equity 14.42% 2025 data

Balance Sheet Ratios

Current Ratio 188.00 2025 data
Equity Ratio 64.30% 2025 data
Asset Turnover 1.32 2025 data

ANUHPHR Revenue, Net Profit & EBITDA — Year-on-Year Growth

ANUHPHR YoY (March 2025 vs Period) — revenue +15.9%, net profit -10.6%, EBITDA -2.9%, expenses +18.1%.

Revenue Growth
+15.9%
Year-over-Year
Net Profit Growth
-10.6%
Year-over-Year
EBITDA Growth
-2.9%
Year-over-Year
Expense Growth
+18.1%
Year-over-Year
Assets Growth
+13.7%
Year-over-Year
Equity Growth
+12.0%
Year-over-Year
Operating Cash Flow Growth
+184.6%
Year-over-Year
Investing Cash Flow Growth
-2100.0%
Year-over-Year
Financing Cash Flow Growth
+44.4%
Year-over-Year

ANUHPHR Income Statement — Revenue, EBITDA & Net Profit

Anuh Pharma revenue ₹778 Cr, EBITDA ₹68 Cr, net profit ₹42 Cr, EPS ₹6.20 (None) — net profit margin 7.0%. Explore ANUHPHR true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 778 671 659 534 492 443 311 325 246 214 330 289
Expenses 710 601 572 476 440 387 284 291 220 184 290 254
EBITDA 68 70 87 57 52 55 27 34 25 30 40 35
Operating Profit Margin % 8.00% 9.00% 12.00% 10.00% 10.00% 10.00% 7.00% 9.00% 8.00% 11.00% 11.00% 11.00%
Depreciation 11 9 9 10 12 15 7 2 2 2 2 3
Interest 0 1 0 0 1 2 1 0 0 0 0 0
Profit Before Tax 56 61 78 48 39 39 19 32 23 28 38 32
Tax 16 14 18 11 9 10 5 9 7 8 12 10
Net Profit 42 47 60 36 31 28 14 23 17 20 26 22
Earnings Per Share (₹) 6.20 9.45 11.98 7.22 6.10 5.67 2.85 9.33 6.59 8.00 10.30 8.78

ANUHPHR Balance Sheet — Assets, Liabilities & Shareholders' Equity

ANUHPHR total assets ₹507 Cr, total equity ₹326 Cr, total liabilities ₹ Cr (2025) — ROE 14.4%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 507 446 405 347 333 326 240 209 189 193 168
Current Assets 376 339 308 259 238 223 152 154 138 151 144
Fixed Assets 58 49 53 61 71 84 21 17 17 18 10
Capital Work in Progress 0 1 0 0 0 0 34 6 0 0 0
Investments 106 97 91 43 31 80 39 66 70 22 29
Other Assets 342 300 261 243 230 163 147 120 101 152 129
LIABILITIES
Total Liabilities
Current Liabilities 2 2 2 3 3 2 1 1 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 326 291 241 214 191 162 165 150 141 119 101
Share Capital 25 25 25 25 25 13 13 13 13 13 4
Reserves & Surplus 301 266 216 189 166 150 152 137 128 107 97

ANUHPHR Cash Flow Statement — Operating, Investing & Financing

Anuh Pharma operating cash flow ₹37 Cr, investing ₹-20 Cr, financing ₹-5 Cr, net cash flow ₹12 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 37 13 54 29 -19 49 7 2 26 17 19
Investing Activities -20 1 -44 -8 52 -77 3 2 -20 -5 -12
Financing Activities -5 -9 -12 -20 -33 22 -7 -5 -4 -9 -8
Net Cash Flow 12 5 -2 2 0 -5 4 -1 2 2 -1